Role of ER-α36 in breast cancer by typical xenoestrogens.

about

GPER-1/GPR30 a novel estrogen receptor sited in the cell membrane: therapeutic coupling to breast cancer.Targeting BCR-ABL+ stem/progenitor cells and BCR-ABL-T315I mutant cells by effective inhibition of the BCR-ABL-Tyr177-GRB2 complex.

P2860

Q39410745-0C84C3A1-42B0-4B91-B9FE-F7D0ACE4E340 Q41279430-D19CA0D0-2401-47BB-A465-BF9693B9EB2E

P2860

Role of ER-α36 in breast cancer by typical xenoestrogens.

Item

http://www.wikidata.org/entity/Q38580235

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Role of ER-α36 in breast cancer by typical xenoestrogens.

@en

type

Item

label

Role of ER-α36 in breast cancer by typical xenoestrogens.

@en

prefLabel

Role of ER-α36 in breast cancer by typical xenoestrogens.

@en

P1476

Role of ER-α36 in breast cancer by typical xenoestrogens.

@en

P2093

Bin Huang

http://www.w3.org/2001/XMLSchema#string

Jun Liu

http://www.w3.org/2001/XMLSchema#string

Xiaodong Ma

http://www.w3.org/2001/XMLSchema#string

Xuejun Pan

http://www.w3.org/2001/XMLSchema#string

Zhixiang Xu

http://www.w3.org/2001/XMLSchema#string

P2860

A positive feedback loop of ER-α36/EGFR promotes malignant growth of ER-negative breast cancer cells

ER-alpha36, a variant of ER-alpha, promotes tamoxifen agonist action in endometrial cancer cells via the MAPK/ERK and PI3K/Akt pathways.

ER-α36, a novel variant of ER-α, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCδ/ERK pathway.

Involvement of estrogen receptor variant ER-alpha36, not GPR30, in nongenomic estrogen signaling.

Breast cancer cell growth inhibition by phenethyl isothiocyanate is associated with down-regulation of oestrogen receptor-alpha36

Estrogen receptors and proliferation markers in primary and recurrent breast cancer

Estrogen receptor-α36 is involved in pterostilbene-induced apoptosis and anti-proliferation in in vitro and in vivo breast cancer

Estrogen receptor-alpha 36 mediates mitogenic antiestrogen signaling in ER-negative breast cancer cells.

Alternate estrogen receptors promote invasion of inflammatory breast cancer cells via non-genomic signaling

Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer.

P2888

s13277-015-4006-x

P304

7355-7364

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13277-015-4006-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1024314578

http://www.w3.org/2001/XMLSchema#string

P698

26337277

http://www.w3.org/2001/XMLSchema#string

Role of ER-α36 in breast cancer by typical xenoestrogens.

about

P2860

P2860

Role of ER-α36 in breast cancer by typical xenoestrogens.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698